OSBPL8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.722620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.165170E-01
Normal-vs-Stage2
1.985580E-01
Normal-vs-Stage3
3.238100E-02
Normal-vs-Stage4
5.968800E-01
Stage1-vs-Stage2
6.532000E-01
Stage1-vs-Stage3
4.226200E-01
Stage1-vs-Stage4
2.814400E-01
Stage2-vs-Stage3
3.082800E-01
Stage2-vs-Stage4
4.406000E-01
Stage3-vs-Stage4
9.706300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.362760E-01
Normal-vs-AfricanAmerican
7.680800E-01
Normal-vs-Asian
2.862200E-02
Caucasian-vs-AfricanAmerican
1.853850E-01
Caucasian-vs-Asian
1.284180E-01
AfricanAmerican-vs-Asian
9.065700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.926810E-01
Normal-vs-Female
1.639970E-01
Male-vs-Female
8.882400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.297010E-01
Normal-vs-Age(41-60Yrs)
3.848800E-01
Normal-vs-Age(61-80Yrs)
1.338020E-01
Normal-vs-Age(81-100Yrs)
2.602000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.450000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.152800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.563800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.391500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.010300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.212000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.356100E-02
Normal-vs-Daily Drinker
1.529650E-02
Normal-vs-Weekly Drinker
8.250100E-02
Normal-vs-Occasional Drinker
4.202200E-01
Normal-vs-Social Drinker
5.783600E-01
Non Drinker-vs-Daily Drinker
2.905200E-01
Non Drinker-vs-Weekly Drinker
8.124200E-01
Non Drinker-vs-Occasional Drinker
2.064000E-01
Non Drinker-vs-Social Drinker
3.080200E-01
Daily Drinker-vs-Weekly Drinker
2.582800E-01
Daily Drinker-vs-Occasional Drinker
7.218400E-02
Daily Drinker-vs-Social Drinker
1.295410E-01
Weekly Drinker-vs-Occasional Drinker
4.042600E-01
Weekly Drinker-vs-Social Drinker
3.996800E-01
Occasional Drinker-vs-Social Drinker
8.801200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.089200E-01
Normal-vs-Grade 2
1.148600E-01
Normal-vs-Grade 3
1.649010E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.476800E-01
Grade 1-vs-Grade 3
2.849800E-01
Grade 1-vs-Grade 4
3.089200E-01
Grade 2-vs-Grade 3
8.398800E-01
Grade 2-vs-Grade 4
1.148600E-01
Grade 3-vs-Grade 4
1.649010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.761180E-01
Normal-vs-NonDiabetic
1.104000E-01
Diabetic-vs-NonDiabetic
6.781800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.020180E-02
Normal-vs-NoPancreatitis
1.677810E-01
Pancreatitis-vs-NoPancreatitis
1.147830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.801830E-01
Normal-vs-N1
1.922400E-01
N0-vs-N1
4.458400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.799970E-01
Normal-vs-TP53-NonMutant
1.968820E-01
TP53-Mutant-vs-TP53-NonMutant
7.435800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
